Clinical spectrum of rectal cancer identifies hallmarks of early‐onset patients and next‐generation treatment strategies
Abstract Background The incidence of colorectal cancer is increasing among young adults and more rectal cancers are reported. This study aimed to identify the clinical features specific for early‐onset rectal cancer and provide insights on cancer management. Methods Early‐onset (<50 years) and la...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-02-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.5120 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846157571329622016 |
|---|---|
| author | Dingcheng Shen Puning Wang Yumo Xie Zhuokai Zhuang Mingxuan Zhu Xiaolin Wang Meijin Huang Yanxin Luo Huichuan Yu |
| author_facet | Dingcheng Shen Puning Wang Yumo Xie Zhuokai Zhuang Mingxuan Zhu Xiaolin Wang Meijin Huang Yanxin Luo Huichuan Yu |
| author_sort | Dingcheng Shen |
| collection | DOAJ |
| description | Abstract Background The incidence of colorectal cancer is increasing among young adults and more rectal cancers are reported. This study aimed to identify the clinical features specific for early‐onset rectal cancer and provide insights on cancer management. Methods Early‐onset (<50 years) and late‐onset (≥50 years) rectal cancer patients from a referral tertiary care center (SYSU cohort) and Surveillance Epidemiology and End Results database (SEER cohort) were included to perform a comprehensive comparison on clinical information. Results A total of 552 and 80,341 patients with stages I–III rectal cancer were included in the SYSU and SEER cohorts, respectively. In the SYSU cohort, early‐onset diseases had significantly higher prevalence of family history of cancer and history of HBV infection and lower incidence of comorbidities (p < 0.05). In addition, early‐onset patients presented more frequently with advanced node stage (N2 stage: 16.9 vs. 9.3%, p = 0.017) and high‐risk features, including mucinous or signet cell carcinomas (21.8 vs. 12.9%, p = 0.014), poorly differentiated tumors (28.8 vs. 15.4%, p = 0.002), and perineural invasion (14.5 vs. 7.9%, p = 0.027) compared with late‐onset patients. However, early‐onset patients received more neoadjuvant (18.5 vs. 11.2%, p = 0.032) and adjuvant treatments (71.0 vs. 45.8%, p < 0.001), and they had better overall survival in both SYSU (HR 0.57, 95% CI: 0.34–0.95; p = 0.029) and SEER (HR 0.38, 95% CI: 0.37–0.40; p < 0.001) cohorts. Conclusion Early‐onset rectal cancers are distinct from late‐onset cases in clinicopathological features, treatment modalities, and outcomes. The clinical trials and studies that are specific for young populations are needed to develop optimal strategies for cancer screening, treatment, and surveillance. |
| format | Article |
| id | doaj-art-1685ce8406054de1aa3880411e45ab34 |
| institution | Kabale University |
| issn | 2045-7634 |
| language | English |
| publishDate | 2023-02-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cancer Medicine |
| spelling | doaj-art-1685ce8406054de1aa3880411e45ab342024-11-25T07:56:32ZengWileyCancer Medicine2045-76342023-02-011233433344110.1002/cam4.5120Clinical spectrum of rectal cancer identifies hallmarks of early‐onset patients and next‐generation treatment strategiesDingcheng Shen0Puning Wang1Yumo Xie2Zhuokai Zhuang3Mingxuan Zhu4Xiaolin Wang5Meijin Huang6Yanxin Luo7Huichuan Yu8Guangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong ChinaDepartment of Colorectal Surgery, The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong ChinaGuangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong ChinaGuangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong ChinaGuangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong ChinaGuangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong ChinaGuangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong ChinaGuangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong ChinaGuangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong ChinaAbstract Background The incidence of colorectal cancer is increasing among young adults and more rectal cancers are reported. This study aimed to identify the clinical features specific for early‐onset rectal cancer and provide insights on cancer management. Methods Early‐onset (<50 years) and late‐onset (≥50 years) rectal cancer patients from a referral tertiary care center (SYSU cohort) and Surveillance Epidemiology and End Results database (SEER cohort) were included to perform a comprehensive comparison on clinical information. Results A total of 552 and 80,341 patients with stages I–III rectal cancer were included in the SYSU and SEER cohorts, respectively. In the SYSU cohort, early‐onset diseases had significantly higher prevalence of family history of cancer and history of HBV infection and lower incidence of comorbidities (p < 0.05). In addition, early‐onset patients presented more frequently with advanced node stage (N2 stage: 16.9 vs. 9.3%, p = 0.017) and high‐risk features, including mucinous or signet cell carcinomas (21.8 vs. 12.9%, p = 0.014), poorly differentiated tumors (28.8 vs. 15.4%, p = 0.002), and perineural invasion (14.5 vs. 7.9%, p = 0.027) compared with late‐onset patients. However, early‐onset patients received more neoadjuvant (18.5 vs. 11.2%, p = 0.032) and adjuvant treatments (71.0 vs. 45.8%, p < 0.001), and they had better overall survival in both SYSU (HR 0.57, 95% CI: 0.34–0.95; p = 0.029) and SEER (HR 0.38, 95% CI: 0.37–0.40; p < 0.001) cohorts. Conclusion Early‐onset rectal cancers are distinct from late‐onset cases in clinicopathological features, treatment modalities, and outcomes. The clinical trials and studies that are specific for young populations are needed to develop optimal strategies for cancer screening, treatment, and surveillance.https://doi.org/10.1002/cam4.5120cancer treatmentclinicopathological featuresearly‐onsetrectal canceryoung |
| spellingShingle | Dingcheng Shen Puning Wang Yumo Xie Zhuokai Zhuang Mingxuan Zhu Xiaolin Wang Meijin Huang Yanxin Luo Huichuan Yu Clinical spectrum of rectal cancer identifies hallmarks of early‐onset patients and next‐generation treatment strategies Cancer Medicine cancer treatment clinicopathological features early‐onset rectal cancer young |
| title | Clinical spectrum of rectal cancer identifies hallmarks of early‐onset patients and next‐generation treatment strategies |
| title_full | Clinical spectrum of rectal cancer identifies hallmarks of early‐onset patients and next‐generation treatment strategies |
| title_fullStr | Clinical spectrum of rectal cancer identifies hallmarks of early‐onset patients and next‐generation treatment strategies |
| title_full_unstemmed | Clinical spectrum of rectal cancer identifies hallmarks of early‐onset patients and next‐generation treatment strategies |
| title_short | Clinical spectrum of rectal cancer identifies hallmarks of early‐onset patients and next‐generation treatment strategies |
| title_sort | clinical spectrum of rectal cancer identifies hallmarks of early onset patients and next generation treatment strategies |
| topic | cancer treatment clinicopathological features early‐onset rectal cancer young |
| url | https://doi.org/10.1002/cam4.5120 |
| work_keys_str_mv | AT dingchengshen clinicalspectrumofrectalcanceridentifieshallmarksofearlyonsetpatientsandnextgenerationtreatmentstrategies AT puningwang clinicalspectrumofrectalcanceridentifieshallmarksofearlyonsetpatientsandnextgenerationtreatmentstrategies AT yumoxie clinicalspectrumofrectalcanceridentifieshallmarksofearlyonsetpatientsandnextgenerationtreatmentstrategies AT zhuokaizhuang clinicalspectrumofrectalcanceridentifieshallmarksofearlyonsetpatientsandnextgenerationtreatmentstrategies AT mingxuanzhu clinicalspectrumofrectalcanceridentifieshallmarksofearlyonsetpatientsandnextgenerationtreatmentstrategies AT xiaolinwang clinicalspectrumofrectalcanceridentifieshallmarksofearlyonsetpatientsandnextgenerationtreatmentstrategies AT meijinhuang clinicalspectrumofrectalcanceridentifieshallmarksofearlyonsetpatientsandnextgenerationtreatmentstrategies AT yanxinluo clinicalspectrumofrectalcanceridentifieshallmarksofearlyonsetpatientsandnextgenerationtreatmentstrategies AT huichuanyu clinicalspectrumofrectalcanceridentifieshallmarksofearlyonsetpatientsandnextgenerationtreatmentstrategies |